We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+6.88%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$2.05B
AUM Growth
+$69.3M
Cap. Flow
-$24.9M
Cap. Flow %
-1.21%
Top 10 Hldgs %
15.01%
Holding
321
New
25
Increased
77
Reduced
178
Closed
26

Top Sells

Rank Stock Value
1
XXIA
Ixia
XXIA
+$25.4M
2
LOCK
LifeLock, Inc.
LOCK
+$25M
3
MATX icon
Matsons
MATX
+$19.2M
4
COLB icon
Columbia Banking Systems
COLB
+$13.4M
5
LIVN icon
LivaNova
LIVN
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 19.23%
2 Industrials 18.93%
3 Technology 18.08%
4 Consumer Discretionary 13.28%
5 Financials 7.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTEK icon
1
Tetra Tech
TTEK
$8.42B
$45.8M 2.23%
5,607,055
-102,035
-2% -$846K
SUPN icon
2
Supernus Pharmaceuticals
SUPN
$2.6B
$34.2M 1.67%
1,093,402
+11,662
+1% +$313K
CRTO icon
3
Criteo S.A. Ordinary Shares
CRTO
$1.08B
$33.1M 1.61%
661,170
-297
-0% -$13.9K
IDTI
4
DELISTED
Integrated Device Technology I
IDTI
$32.7M 1.59%
1,379,793
-29,245
-2% -$718K
POOL icon
5
Pool Corp
POOL
$6.78B
$31.7M 1.54%
265,713
-1,787
-0.7% -$200K
STMP
6
DELISTED
Stamps.com, Inc.
STMP
$30.9M 1.5%
260,717
-1,227
-0.5% -$152K
EFOR
7
Everforth Inc
EFOR
$1.13B
$26.7M 1.3%
+550,509
New +$25.5M
HCSG icon
8
Healthcare Services Group
HCSG
$1.59B
$24.5M 1.19%
568,968
-15,472
-3% -$636K
GMED icon
9
Globus Medical
GMED
$10.7B
$24.5M 1.19%
827,526
-19,656
-2% -$536K
NKTR icon
10
Nektar Therapeutics
NKTR
$2.36B
$24.1M 1.17%
68,343
-245
-0.4% -$55.1K
LGND icon
11
Ligand Pharmaceuticals
LGND
$5.85B
$23.2M 1.13%
351,859
+14,307
+4% +$941K
FN icon
12
Fabrinet
FN
$15.9B
$23M 1.12%
547,317
-1,169
-0.2% -$48.6K
CEB
13
DELISTED
CEB Inc.
CEB
$22.7M 1.11%
288,912
+5,055
+2% +$389K
DORM icon
14
Dorman Products
DORM
$3.98B
$22.3M 1.09%
271,513
-7,766
-3% -$577K
SFM icon
15
Sprouts Farmers Market
SFM
$8.12B
$22.2M 1.08%
+960,653
New +$18.8M
IMAX icon
16
IMAX
IMAX
$2.61B
$21.2M 1.04%
624,820
-17,338
-3% -$565K
DY icon
17
Dycom Industries
DY
$12B
$21.1M 1.03%
227,060
+106,246
+88% +$9.02M
OZK icon
18
Bank OZK
OZK
$5.59B
$21.1M 1.03%
405,502
-3,614
-0.9% -$194K
LCII icon
19
LCI Industries
LCII
$2.49B
$21.1M 1.03%
211,227
-1,237
-0.6% -$133K
CAKE icon
20
Cheesecake Factory
CAKE
$5.11B
$21.1M 1.03%
332,347
-2,156
-0.6% -$131K
TSEM icon
21
Tower Semiconductor
TSEM
$25.3B
$20.9M 1.02%
908,892
+250,109
+38% +$5.49M
RAMP icon
22
LiveRamp
RAMP
$2.3B
$20.6M 1%
724,394
-20,384
-3% -$568K
MWA icon
23
Mueller Water Products
MWA
$3.96B
$20.3M 0.99%
1,715,116
-44,678
-3% -$567K
BECN
24
DELISTED
Beacon Roofing Supply, Inc.
BECN
$20.2M 0.99%
411,560
+156,002
+61% +$7.2M
SXT icon
25
Sensient Technologies
SXT
$5.24B
$20.1M 0.98%
253,770
-6,663
-3% -$524K

Similar funds

Rice Hall James & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Rice Hall James & Associates held 321 positions worth $2.05B, up 3.5% from $1.98B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Rice Hall James & Associates's Q1 2017 filing shows 25 new, 77 increased, 178 reduced and 26 closed positions. Its largest new stake was Everforth Inc: 550,509 shares worth $26.7M. The largest sale was Ixia, an estimated $25.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

  • Rice Hall James & Associates's largest Q1 2017 buy was Everforth Inc: 550,509 shares worth $26.7M.
  • Rice Hall James & Associates added most to Dycom Industries in Q1 2017, an estimated $9.02M increase.
  • Rice Hall James & Associates's biggest Q1 2017 reduction was Oxford Industries, cutting an estimated $12.4M.
  • Rice Hall James & Associates fully exited Ixia in Q1 2017, selling an estimated $25.4M.
  • Rice Hall James & Associates's ten largest holdings make up 15% of its $2.05B portfolio in Q1 2017.
  • Rice Hall James & Associates opened 25 new positions and closed 26 in Q1 2017.
  • Rice Hall James & Associates's portfolio value rose 3.5% quarter-over-quarter to $2.05B.

Based on Rice Hall James & Associates's 13F filing for Q1 2017, filed 19 Apr 2017.